JOINSTAR showcased the Jet-iStar platforms (JS 800 and JS800 Plus) and its full range of twenty one Point-of-Care assays covering a range of key diseases. A major focus was its wide range of the Infectious disease tests including the patented novel Heparin Binding Protein (HBP) assay, which has been shown to play a key role in the management of Sepsis patients. The JOINSTAR booth welcomed experts, scholars and businesses from various Asian countries and there was a very positive response for the Joinstar products and offerings.

asdas (1)

asdas (2)

asdas (3)

asdas (4)

Post time:Nov-05-2022

Post time: 11-05-2022
  • Previous:
  • Next:
  • Leave Your Message